Search clinical trials for: Nivolumab plus Ipilimumab
Total 6680 results
-
TriSalus Life Sciences, Inc.Active, not recruitingHepatocellular Carcinoma | Intrahepatic CholangiocarcinomaUnited States
-
BioNTech US Inc.Apexigen, Inc.TerminatedMetastatic MelanomaUnited States
-
Bristol-Myers SquibbActive, not recruitingA Study of BMS-986253 in Combination With Nivolumab or Nivolumab Plus Ipilimumab in Advanced CancersMelanoma | CancerUnited States, Poland, Italy, Belgium, France, Australia, Canada, Germany, Spain, Sweden, Switzerland, United Kingdom
-
ArdigenNational Center for Research and Development, Poland; The Institute of Bioorganic...UnknownMelanoma | Healthy Volunteers | Metagenome | Immunotherapy | MicrobiomePoland
-
Providence Health & ServicesBristol-Myers Squibb; ExelixisActive, not recruitingRefractory Cutaneous MelanomaUnited States
-
Bristol-Myers SquibbOno Pharmaceutical Co. LtdCompleted
-
Bristol-Myers SquibbMedarex; Ono Pharma USA IncCompleted
-
Memorial Sloan Kettering Cancer CenterRecruitingMelanoma | Melanoma Stage IIIUnited States
-
Bristol-Myers SquibbCompletedNon-Small Cell Lung CancerItaly, United States, Argentina, Belgium, Germany, Israel, Poland, Spain, Turkey, Australia, Chile, France
-
University of Texas Southwestern Medical CenterWithdrawnMelanoma | Metastatic MelanomaUnited States
-
Sarcoma Oncology Research Center, LLCBristol-Myers SquibbRecruitingSAINT:Trabectedin, Ipilimumab and Nivolumab as First Line Treatment for Advanced Soft Tissue SarcomaAdvanced Soft Tissue Sarcoma | Metastatic Soft Tissue SarcomaUnited States
-
Bristol-Myers SquibbActive, not recruitingHepatocellular CarcinomaGermany, Romania, United States, Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, China, Czechia, France, Hong Kong, Italy, Japan, Korea, Republic of, Poland, Puerto Rico, Russian Federation, Singapore, Spain, Switzerland and more
-
Sumitomo Pharma America, Inc.Completed
-
Bristol-Myers SquibbOno Pharmaceutical Co. LtdCompletedVarious Advanced CancerUnited States, Belgium, France, Germany, Japan, Korea, Republic of, Mexico, Netherlands, Spain, Taiwan, United Kingdom
-
Robert R. McWilliams, MDBristol-Myers Squibb; Hoosier Cancer Research NetworkActive, not recruiting
-
Shanghai Henlius BiotechRecruitingHealthy Male VolunteersChina
-
University of Texas Southwestern Medical CenterTerminated
-
University of California, IrvineExelixisRecruitingHCC | Hepatocellular CarcinomaUnited States
-
Dana-Farber Cancer InstituteBiohaven Pharmaceuticals, Inc.TerminatedMelanoma | Metastatic MelanomaUnited States
-
Jounce Therapeutics, Inc.Completed
-
H. Lee Moffitt Cancer Center and Research InstituteBristol-Myers Squibb; MultiVir, Inc.TerminatedSmall Cell Lung Cancer | Lung Cancer | Relapsed Small Cell Lung CancerUnited States
-
National Cancer Institute (NCI)SuspendedDiffuse Glioma | Secondary Glioblastoma | Glioblastoma, IDH-Wildtype | Astrocytoma, IDH-Mutant, Grade 4United States, Puerto Rico
-
The Netherlands Cancer InstituteBristol-Myers SquibbRecruitingColon CarcinomaNetherlands
-
Takayuki YoshinoOno Pharmaceutical Co. LtdRecruiting
-
Fondazione Melanoma OnlusClinical Research Technology S.r.l.Active, not recruitingMetastatic MelanomaItaly, Germany, Spain, Greece, Austria, France, Poland, Sweden, Switzerland, United Kingdom
-
Ultimovacs ASACompletedMalignant MelanomaUnited States, Belgium, United Kingdom, Norway
-
Radboud University Medical CenterBristol-Myers SquibbActive, not recruitingProstatic Neoplasms, Castration-ResistantNetherlands
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Bristol-Myers SquibbTerminatedNeuroendocrine Tumors | Carcinoid TumorUnited States
-
Kristen GanjooBristol-Myers SquibbCompletedSoft Tissue SarcomaUnited States
-
ExelixisActive, not recruitingRenal Cell CarcinomaUnited States, Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, Czechia, Finland, France, Germany, Hong Kong, Hungary, Israel, Italy, Korea, Republic of, Mexico, Netherlands, New Zealand, Poland, Singapore, Spain, Taiwan, United...
-
H. Lee Moffitt Cancer Center and Research InstituteRecruitingMerkel Cell Carcinoma | Cutaneous Melanoma | Cutaneous Squamous Cell CarcinomaUnited States
-
Hoffmann-La RocheCompletedMelanomaUnited States, Italy, Australia, France, Spain, Netherlands
-
Bristol-Myers SquibbActive, not recruitingAdvanced or Metastatic Solid TumorsUnited States, Germany, Spain, United Kingdom, Italy, Canada, Denmark, Finland
-
Bristol-Myers SquibbOno Pharmaceutical Co. LtdActive, not recruitingHepatocellular CarcinomaUnited States, Singapore, Spain, United Kingdom, Germany, Italy, Canada, France, Hong Kong, Japan, Korea, Republic of, Puerto Rico, Taiwan
-
University of Alabama at BirminghamWithdrawnCarcinosarcoma of Ovary | Carcinosarcoma of Uterus | Carcinosarcoma of VaginaUnited States
-
ArdigenMałopolskie Centre of EntrepreneurshipUnknownNon Small Cell Lung Cancer | Immunotherapy | Neoantigens | Neoepitopes | Next Generation Sequencing (NGS) | Personalized Neoantigen Cancer VaccinePoland
-
University of Wisconsin, MadisonBristol-Myers Squibb; National Cancer Institute (NCI); AnYxis Immuno-Oncology... and other collaboratorsSuspended
-
H. Lee Moffitt Cancer Center and Research InstituteBristol-Myers Squibb; Gilead SciencesActive, not recruitingMetastatic Urothelial CarcinomaUnited States
-
Roberto PiliBristol-Myers Squibb; Syndax Pharmaceuticals; Indiana University School of MedicineActive, not recruitingRenal Cell CarcinomaUnited States
-
Bristol-Myers SquibbCompleted
-
National Cancer Institute (NCI)TerminatedMetastatic Melanoma | Stage III Cutaneous Melanoma AJCC v7 | Stage IV Cutaneous Melanoma AJCC v6 and v7 | Stage IIIC Cutaneous Melanoma AJCC v7 | BRAF V600E Mutation Present | BRAF V600K Mutation Present | Stage IIIA Cutaneous Melanoma AJCC v7 | Stage IIIB Cutaneous Melanoma AJCC v7United States
-
Lahey ClinicCompletedDry Eye SyndromeUnited States
-
Abramson Cancer Center at Penn MedicineTerminatedRenal Cell Carcinoma | Renal Cell Carcinoma Stage IVUnited States
-
Bristol-Myers SquibbOno Pharmaceutical Co. LtdActive, not recruitingUrothelial CancerRussian Federation, United States, Brazil, Spain, Chile, Korea, Republic of, Argentina, Australia, Canada, China, Czechia, Denmark, Finland, France, Germany, Greece, Israel, Italy, Japan, Mexico, Netherlands, Norway, Peru, Poland, Romania, Swed... and more
-
Jeffrey ClarkeCompletedNon-small Cell Lung CancerUnited States
-
M.D. Anderson Cancer CenterRecruitingRenal Cell CarcinomaUnited States
-
Mirati Therapeutics Inc.Active, not recruitingAdvanced or Metastatic Solid MalignanciesUnited States
-
University of FloridaNational Center for Complementary and Integrative Health (NCCIH)TerminatedObesity | Oxidative StressUnited States
-
Italian Network for Tumor BiotherapyBristol-Myers SquibbCompletedMetastatic Malignant MelanomaItaly
-
Scott AntoniaRecruitingLung Cancer MetastaticUnited States